Optical imaging of absorption and distribution of RITC-SiO2 nanoparticles after oral administration

International Journal of Nanomedicine

Volumn 9, Issue , 2014, Pages 243-250

  Lee, Chang Moon ^a   Lee, Tai Kyoung ^b   Kim, Dae Ik ^a   Kim, Yu Ri ^c   Kim, Meyoung Kon ^c   Jeong, Hwan Jeong ^b   Sohn, Myung Hee ^b   Lim, Seok Tae ^b  

^a Chonnam National University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Korea University   (South Korea)

Author keywords

Oral exposure; Rhodamine B isothiocyanate; RITC SiNP; Silica nanoparticles

Indexed keywords

FLUORESCENT DYE; NANOPARTICLE; RHODAMINE; RHODAMINE ISOTHIOCYANATE; SILICON DIOXIDE;

ANIMAL; CHEMISTRY; FLUORESCENCE IMAGING; MOUSE; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PROCEDURES; TISSUE DISTRIBUTION;

ADMINISTRATION, ORAL; ANIMALS; FLUORESCENT DYES; MICE; MICE, NUDE; NANOPARTICLES; OPTICAL IMAGING; RHODAMINES; SILICON DIOXIDE; TISSUE DISTRIBUTION;

EID: 84947443451     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S57938     Document Type: Article

References (32)

1. Yu Y, Li Y, Wang W, et al. Acute Toxicity of amorphous silica nanoparticles in intravenously exposed ICR mice. PLoS One. 2013;8(4):e61346.
2. Yang X, Liu J, He H, et al. SiO2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells. Part Fibre Toxicol. 2010;7:1.
3. Freitas Jr RA. Nanotechnology, nanomedicine and nanosurgery. Int J Surg. 2005;3(4):243–246.
4. Li Y, Sun L, Jin M, et al. Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells. Toxicol In Vitro. 2011;25(7):1343–1352.
5. Gong C, Tao G, Yang L, Liu J, He H, Zhuang Z. The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells. Mol Biol Rep. 2012;39(4):4915–4925.
6. Orts-Gil G, Natte K, Österle W. Multi-parametric reference nanomaterials for toxicology: state of the art, future challenges and potential candidates. RSC Adv. 2013;3:18202–18215.
7. Lee CM, Jeong HJ, Yun KN, et al. Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure. Int J Nanomed. 2012;7:3203–3209.
8. Lee CM, Jeong HJ, Kim DW, Sohn MH, Lim ST. The effect of fluorination of zinc oxide nanoparticles on evaluation of their biodistribution after oral administration. Nanotechnology. 2012;23(20):205102.
9. Gibson N, Holzwarth U, Abbas K, et al. Radiolabelling of engineered nanoparticles for in vitro and in vivo tracing applications using cyclotron accelerators. Arch Toxicol. 2011;85(7):751–773.
10. Natte K, Behnke T, Orts-Gil G, et al. Synthesis and characterization of highly fluorescent core-shell nanoparticles based on Alexa dyes. J Nanopart Res. 2012;14:680.
11. Areses P, Agüeros MT, Quincoces G, et al. Molecular imaging techniques to study the biodistribution of orally administered 99mTc-labelled naive and ligand-tagged nanoparticles. Mol Imaging Biol. 2011;1(6):1215–1223.
12. Orts-Gil G, Natte K, Thiermann R, et al. On the role of surface composition and curvature on biointerface formation and colloid stability of nanoparticles in a protein-rich model system. Colloids Surf B Biointerfaces. 2013;108:110–119.
13. Chen JK, Shih MH, Peir JJ, et al. The use of radioactive zinc oxide nanoparticles in determination of their tissue concentrations following intravenous administration in mice. Analyst. 2010;135(7): 1742–1746.
14. He Q, Zhang Z, Gao F, Li Y, Shi J. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small. 2011;7(2):271–280.
15. Park YH, Bae HC, Jang Y, et al. Effect of the size and surface charge of silica nanoparticles on cutaneous toxicity. Mol Cell Toxicol. 2013;9(1): 67–74.
16. Kim JS, Yoon TJ, Yu KN, et al. Cellular uptake of magnetic nanoparticle is mediated through energy dependent endocytosis in A549 cells. J Vet Sci. 2006;7(4):321–326.
17. Huang X, Li L, Liu T, et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano. 2011;5(7):5390–5399.
18. Fu C, Liu T, Liu H, Chen D, Tang F. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials. 2013;34(10):2565–2575.
19. Awaad A, Nakamura M, Ishimura K. Imaging of size-dependent uptake and identification of novel pathways in mouse Peyer’s patches using fluorescent organosilica particles. Nanomed Nanotechnol Biol Med. 2011;8(5):627–636.
20. Rancan F, Gao Q, Graf C, et al. Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. ACS Nano. 2012;6(8):6829–6842.
21. Moulari B, Pertuit D, Pellequer Y, Lamprecht A. The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis. Biomaterials. 2008;29(34):4554–4560.
22. Jani PU, McCarthya DE, Florence AT. Nanosphere and microsphere uptake via Peyer’s patches: observation of the rate of uptake in the rat after a single oral dose. Int J Pharm. 1992;86(2–3):239–246.
23. Jani PU, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol. 1990;42(12):821–826.
24. Manisha PD, Vinod L, Gordon LA, Robert JL. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res. 1996;13(12):1838–1845.
25. Sass W, Dreyer HP, Seifert J. Rapid insorption of small particles in the gut. Am J Gastroenterol. 1990;85(3):255–260.
26. Florence AT. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res. 1997;14(3):259–266.
27. Florence AT, Hillery AM, Hussain N, Jani PU. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. J Drug Target. 1995;3(1):65–70.
28. Roberts RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE. Role of the kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci. 2007;96(1):2–15.
29. Lanthier N, Molendi-Coste O, Horsmans Y, van Rooijen N, Cani PD, Leclercq IA. Kupffer cell activation is a causal factor for hepatic insulin resistance. Am J Physiol Gastrointest Liver. 2010;298(1): G107–G116.
30. Kulkarni SA, Feng SS. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res. 2013;30(10):2512–2522.
31. Borak B, Biernat P, Preshcha A, Baszczuk A, Pluta J. In vivo study on the biodistribution of silica particles in the bodies of rats. Adv Clin Exp Med. 2012;21(1):13–18.
32. Yu T, Greish K, McGill LD, Ray A, Ghandehari H. Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity; their vasculature effect and tolerance threshold. ACS Nano. 2012;6(3):2289–2301.